TXN:NASDAQTexas Instruments Incorporated Analysis
Data as of 2026-03-09 - not real-time
$196.20
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Texas Instruments is trading at $196.2, well above its DCF fair value of $107.5, indicating a sizable premium. The stock sits just above the 20‑day SMA of 213.8 and the 50‑day SMA of 203.1, while the 200‑day SMA remains at 190.0, suggesting a short‑term pull‑back risk despite a bullish overall trend. Technical momentum is mixed: RSI is at 35 (near oversold), but the MACD histogram is negative and the signal line is bearish, flagging potential downside pressure toward the support level of $189.7. Fundamentals show solid revenue growth of 10.4% YoY, strong gross (57%) and operating (34%) margins, but free cash flow is slightly negative and the payout ratio exceeds 100%, raising dividend sustainability concerns. Valuation metrics are high – trailing P/E of 36 versus an industry average of 36.9 and forward P/E of 24.8 – positioning the stock as a growth‑oriented, possibly overvalued play. The market sentiment is extremely bullish, reflected by a Fear & Greed Index of Extreme Greed, yet volatility is elevated at 38.9% over 30 days and beta exceeds 1.3, underscoring heightened risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price is near technical support at $189.7
- RSI suggests potential bounce but MACD remains bearish
- High valuation premium limits upside in the near term
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Revenue growth of 10% and strong margins support earnings stability
- Negative free cash flow and high debt-to-equity increase financial risk
- Analyst median target (~$226) implies modest upside but valuation remains stretched
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strategic partnership with NVIDIA expands high‑growth robot and AI markets
- Analog semiconductor demand remains resilient and defensive
- Capital management focus on free cash flow per share aims to improve dividend sustainability
Key Metrics & Analysis
Financial Health
Revenue Growth10.40%
Profit Margin28.28%
P/E Ratio36.0
ROE30.15%
ROA10.93%
Debt/Equity90.82
P/B Ratio10.9
Op. Cash Flow$7.2B
Free Cash Flow$-300624992
Industry P/E36.8
Technical Analysis
TrendBullish
RSI35.1
Support$189.70
Resistance$231.32
MA 20$213.82
MA 50$203.05
MA 200$189.97
MACDBearish
VolumeStable
Fear & Greed Index100
Valuation
Fair Value$107.54
Target Price$221.55
Upside/Downside12.92%
GradeOvervalued
TypeGrowth
Dividend Yield2.94%
Risk Assessment
Beta1.33
Volatility38.91%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.